Trafermin

fibroblast growth factor-2 (FGF-2) · Kaken Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Trafermin, covering 2008-02-05 to 2014-08-05. Get the full timeline:

Most recent: Clinical Trial Update: The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study [Phase 3]